NCT00366301View on ClinicalTrials.gov

The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes

PHASE4TerminatedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

Insulin glargine injection

Once daily for 14 weeks

DRUG

metformin

Up to 4 pils per day (2g per day) maximum

DRUG

Placebo pill

Up to 4 pills per day

Trial Locations (1)

02215

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Brigham and Women's Hospital

OTHER